A prospective, single-arm, single-center clinical study of Sintilizumab+bevacizumab combined with standard chemotherapy in the second-line treatment of metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Interventions: test group:Sintilizumab combined with bevacizumab Primary outcome(s): Disease-free survival Study Design: Single arm
创建时间：
2022-04-15
